Molecular oncology is revolutionizing cancer care by using genetic profiling to tailor personalized treatments, improving efficacy, minimizing adverse events, and paving the way for advanced therapies ...

Introduction: SYNGR4 is considered to be one of the causative genes for amyotrophic lateral sclerosis, but its role in breast cancer development has not been revealed. Methods: The expression of ...

Introduction: The development of nanobodies targeting Programmed Cell Death Protein-1 (PD-1) offers a promising approach in cancer immunotherapy. This study aims to design and characterize a ...

When Sidney Farber and colleagues conceived the folic acid analogs and subsequently tested these compounds in children with leukemia showing disease remissions in 1948 1, following the thrilling ...

Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Essen, Germany Consolidation with PD-1/PD-L1-based immune checkpoint blockade after concurrent platinum-based ...